A key target of ADI-100 is Glutamic Acid Decarboxylase (GAD), an enzyme implicated in Type 1 Diabetes, Stiff Person Syndrome, and several other autoimmune conditions. This approach is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback